Medis
Manufacturing · Slovenia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Brnčičeva, Ljubljana-Črnuče, Ljubljana...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Medis
Founded in 1985, Medis is a pharmaceutical company specializing in prescription medicines covering the majority of therapeutic areas such as Pain Management, Rheumatology, and the Central Nervous System. Medis is located in Slovenia.Explore more
Popular SearchesSIC Code 28,283NAICS Code 32,325Show moreMedis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Medis launches new products
Funding: Get notified immidiatlly once Medis has new funding data
Check if Medis has recently received funding, and reach out quickly before it becomes old news!
Check out if Medis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Medis
Website visits: Recent activity has been detected on your website
Click to see if Medis had a recent Job posting/layoffs
Earning: See what the market has to say on Medis recently announced quarterly report
Medis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Medis
Find 2 more new buyers
Company Profile Activity
Activity Insights
Medis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medis.
Medis News & Media
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®Medis Group ends its 2020 financial year with almost 12% revenue growth
LJUBLJANA, Slovenia, Feb. 18, 2021 /PRNewswire/ -- Pharmaceutical company Medis as a part of Medis Group ended its 2020 financial year with revenues of € 136.1 million, up 11.9 percent from the previous year. Growth was particularly noticeable in foreign markets, where most of the revenue...Medis Selects Veeva CRM to Deliver Personalized Experiences to Healthcare Professionals
PLEASANTON, Calif.--(BUSINESS WIRE)-- #cloud--Medis switched to multichannel Veeva CRM in 15 countries across Central and Eastern Europe to advance its commercial strategy.Alimera Sciences Signs Distribution Agreement With Medis Pharmaceutical to Commercialize Iluvien® in Austria and the Czech Republic
Medis will enable immediate access of ILUVIEN to patients in Austria, and will manage reimbursement negotiations for ILUVIEN in the Czech Republic Medis will enable immediate access of ILUVIEN to patients in Austria, and will manage reimbursement negotiations for ILUVIEN in the Czech Republic
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medis
Sign Up For FreeTo access detailed company insights
Founded in 1985, Medis is a pharmaceutical company specializing in prescription medicines covering the majority of therapeutic areas such as Pain Management, Rheumatology, and the Central Nervous System. Medis is located in Slovenia.... Read More
